drugset / Trial / NCT00793182

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

NCT00793182

Phase 4 Terminated 6 enrolled Guerbet
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to evaluate the contrast-induced nephropathy (CIN) rate in subjects randomized to receive either Ioversol or Iodixanol for contrast-enhanced computed tomography.

Timeline

Start
2009-01
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent 125 ml Intravenous
Comparator Iodixanol Diagnostic / imaging agent 320 mg/ml Intravenous
Comparator Ioversol Small molecule 125 ml Intravenous
Comparator Ioversol Small molecule 320 mg/ml Intravenous